Multiple studies have confirmed that miR-34c-5p inhibits EMT by targeting Notch1 in bladder cancer, cervical cancer and endometriosis (Xu, et al. 2019; Luo, et al. 2020). Here, NOTCH1 is linked to urinary bladder cancer.